|
Market Cap (5-Jul) $86,511,600 (718th) |
Close (30-Jun) $0.63 |
Volume (30-Jun) 55,179 |
Shortsold (19-Jun) 190,561 (0.07%) (455th) |
|
52w High $0.57 |
52w Low $0.275 |
P/E - |
EPS -0.09 |
RCE released this announcement to the ASX on 21 October 2020, 11:35. The announcement is marked as price sensitive, and is 10 page(s) in length and 797.75kb in size.
You can view all announcements from RCE and see how they appear on a price chart on the announcements page.
At the date of this announcement, RCE was 0.001% short sold according to ASIC data. It was ranked the 616th most shorted stock on the ASX. It is now ranked as the 455th most shorted stock on the ASX with 0.066% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from RCE | |
|---|---|
| Ethics Approval for Phase I/II UTI Trial Expansion | 29 June 2023, 13:49 |
| Change of Director's Interest Notice - J Graham | 26 June 2023, 15:58 |
| DFI Clinical Trial Outpatient Nurses Appointed | 29 May 2023, 10:54 |
| Appendix 4C and Activity Report | 21 October 2020, 11:35 |
| HREC Approval to Start Phase I/II Burns Wound Study | 16 October 2020, 9:38 |
| Trading Halt | 14 October 2020, 14:44 |
| Pause in trading | 14 October 2020, 14:15 |
You must be logged in to post a reply.
Recce Pharmaceuticals Ltd 